MedPath

Study on the treatment of oligoasmatospermia with Baihe Yuzi prescription and its mechanism

Phase 1
Completed
Conditions
Male infertility
Registration Number
ITMCTR2200005977
Lead Sponsor
Hebei Hospital of Traditional Chinese Medicine, no. 389, East Zhongshan Road, Chang 'an District, Shijiazhuang city, Hebei Province
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Meet the diagnostic criteria, the husband and wife have been living regularly for more than one year, have no contraceptive measures and have no abnormalities in spouse examination; Patients who did not use drugs to improve sperm quality before entering the clinical study, or who have used drugs but have passed the washout period of 3 months; The five levels of serum sex hormones were within the normal value. The patient agrees and signs the informed consent

Exclusion Criteria

Varicocele grade 2 and above; With clinical symptoms or abnormal tongue coating and pulse; A history of mumps or significantly elevated FSH levels; Chromosomal or AZF gene abnormality; Unable to escape from toxic, high temperature, radiation and other special environment; Tumors found in hypothalamus and pituitary gland.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
seminal plasma anti-mullerian hormone;semen parameters;
Secondary Outcome Measures
NameTimeMethod
Seminal plasma testosterone, estradiol;
© Copyright 2025. All Rights Reserved by MedPath